How troubles at a factory in India led to a U.S. cancer-drug shortage
Washington Post
Intas Pharmaceuticals in India made a widely used cancer drug in the U.S. An inspection exposed problems — and the fragility of the U.S. generic-drug supply.
https://www.washingtonpost.com/business/2023/06/27/cancer-drug-shortage-generics/